Non-invasive prenatal diagnosis (NIPD) is based on fetal DNA analysis starting from a
simple peripheral blood sample, thus avoiding risks associated with conventional invasive …

Alloimmunization to red blood cell (RBC) antigens represents a challenge for physicians
caring for women of child bearing potential. Exposure to non-self RBC antigens may occur …

BACKGROUND Noninvasive prenatal testing (NIPT) for monogenic diseases by use of PCR-
based strategies requires precise quantification of mutant fetal alleles circulating in the …

Background: Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of
fetus and newborn (HDFN) aims to guide clinicians and the immunized women to focus on …

The animal's blood is the most complicated and important biological liquid for veterinary
medicine. In addition to standard methods that are always in use, recent technologies such …

Non-invasive prenatal testing (NIPT) is based on the detection and characterization of
circulating cell-free fetal DNA (ccffDNA) in maternal plasma and aims to identify genetic …

The current recommended testing algorithm for assessing the alloimmunized pregnancy
utilized by many obstetricians in the United States (US) fails to consider the most recent …

Detection and characterization of circulating cell-free fetal DNA (cffDNA) from maternal
circulation requires an extremely sensitive and precise method due to very low cffDNA …

Background Non-invasive foetal RHD genotyping can predict haemolytic disease of the
foetus and the newborn in pregnancies with anti-D alloantibodies and also avoid antenatal …

Background Fetal RHD genotyping of cell-free fetal DNA (cff-DNA) from RhD-negative
pregnant women can be used to guide anti-D prophylaxis: the knowledge of fetal RhD type …